Covington represented the underwriters on the deal.Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced…
Marinus Pharmaceuticals’ $60 Million Public Offering
![](https://globallegalchronicle.com/wp-content/uploads/2022/11/marinus-pharmaceuticals-60-million-public-offering_6375e3c06b7de.jpeg)